Antiproliferative and antiangiogenic activities of genistein in human renal cell carcinoma

Urology

Volumn 64, Issue 2, 2004, Pages 389-393

  Sasamura, Hiroto ^a   Takahashi, Atsushi ^a   Yuan, Jinyang ^a   Kitamura, Hiroshi ^a   Masumori, Naoya ^a   Miyao, Noriomi ^a   Itoh, Naoki ^a   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENISTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; INHIBITION KINETICS; KIDNEY CARCINOMA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SOYBEAN; STATISTICAL SIGNIFICANCE;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CARCINOMA, RENAL CELL; CELL DIVISION; CELL LINE, TUMOR; DIFFUSION CHAMBERS, CULTURE; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GENISTEIN; HUMANS; KIDNEY NEOPLASMS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC;

EID: 4143059348     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.03.045     Document Type: Article

References (28)

1. Fotsis T., Pepper M., Adlercreutz H., et al. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr. 125:1995;790S-797S
2. 2/M arrest, and apoptosis. J Cell Biochem. 69:1998;44-54
3. Constanitinou A., Kiguchi K., Huberman A. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 50:1990;2618-2624
4. Hunakova L., Sedlak J., Klobuicka M., et al. Tyrosine kinase inhibitor-induced differentiation of K-562 cells alterations of cell cycle and cell surface phenotype. Cancer Lett. 81:1994;81-87
5. Akiyama T., Ishida J., Nakagawa S., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinase. J Biol Chem. 262:1987;5592-5595
6. Okura A., Arakawa H., Oka H., et al. Effect of genistein on topoisomerase activity on the growth of [VAL 12] Ha-ras-transformed NIH3T3 cells. Biochem Biophys Res Commun. 157:1988;183-189
7. Adlercreutz H., Bannwart C., Wahala K., et al. Inhibition of human aromatase by mammalian ligands and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol. 44:1993;147-153
8. Mäkelä S., Poutanen M., Kostian M.L., et al. Inhibition of 17β-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc Soc Exp Biol Med. 217:1998;310-316
9. Zhou J.R., Mukherjee P., Gugger E.T., et al. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res. 58:1998;5231-5238
10. Sasamura H., Takahashi A., Miyao N., et al. Inhibitory effect on expression of angiogenic factors by antiangiogenic agents in renal cell carcinoma. Br J Cancer. 86:2002;768-773
11. Takahashi A., Sasaki H., Kim S.J., et al. Markedly Increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res. 54:1994;4233-4237
12. Miyao N., Tsukamoto T., Kumamoto Y. Establishment of three human renal cell carcinoma cell lines (SMKT-R-1, SMKT-R-2, and SMKT-R-3) and their characters. Urol Res. 17:1989;317-324
13. Otani N., Tsukamoto T., Kumamoto Y., et al. Study on in vitro invasive potential of renal cell carcinoma cell lines and effect of growth factors (EGF and TGF-β1). Jpn J Urol. 82:1991;613-619
14. Funahashi Y., Wakabayashi T., Senba T., et al. Establishment of a quantitative mouse dorsal sac model and its application to evaluate a new angiogenesis inhibitor. Oncol Res. 11:1999;319-329
15. Song C.H., Levitt S.H. Quantitative study of vascularity in Walker carcinoma 256. Cancer Res. 31:1971;587-589
16. Peretz D., Kimel N., Fujii D.K., et al. Overexpression of basic fibroblast growth factor complementary DNA in Ha-ras-transformed cells correlates with a decreased incidence of tumor necrosis. Cancer Res. 53:1993;158-164
17. Balbaa M., Honke K., Makita A. Regulation of glycolipid sulfotransferase by tyrosine kinases in human renal cancer cells. Biochem Biophys Act. 1299:1996;141-145
18. WAF1, downregulation of cyclin B, and induction of apoptosis in prostate cancer cells. Nutr Cancer. 32:1998;123-131
19. Park B.S., Baek S.J., Song K.H., et al. Genistein-induced apoptosis of p815 mastocytoma cells is mediated by Bax and augmented by a proteasome inhibitor, lactacystin. Nutr Cancer. 42:2002;248-255
20. Gong L., Li Y., Nedeljkovic-Kurepa A., et al. Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cell. Oncogene. 22:2003;4702-4709
21. Folkman J. Tumor angiogenesis therapeutic implications. N Engl J Med. 285:1971;1182-1186
22. Ausprunk D.H., Knighton D.R., Folkman J. Vascularization of normal and neoplastic tissue grafted to the chick chorioallantois. Am J Pathol. 79:1975;597-618
23. Gimbrone M.A. Jr, Cotran R.S., Leapman S.B., et al. Tumor growth and neovascularization a experimental model using rabbit cornea. J Natl Cancer Inst. 52:1974;413-427
24. Folkman J., Merler E., Abernathy C., et al. Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 133:1971;275-288
25. Sakamoto N., Tanaka N.G., Tohgo A., et al. Heparin plus cortisone acetate inhibit tumor growth by blocking endothelial cell proliferation. Cancer J. 1:1986;55-58
26. Shao Z.M., Wu J., Shen Z.Z., et al. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res. 58:1998;4851-4857
27. Campbell S.C. Advances in angiogenesis research relevance to urological oncology. J Urol. 158:1997;1663-1667
28. Mukhopadhyay D., Tsiokas L., Zhou X.M., et al. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature. 375:1995;577-581